TNFRSF11A and breast cancer: In contrast, genetic inactivation of the RANKL receptor RANK in mammary‐gland epithelial cells and deletion of RANK from the mammary epithelium prevent hormone replacement therapy‐induced epithelial proliferation and the incidence of BC.